Clinical Trial: MMA Infusion of Lidocaine for Treatment of Headache in Patients With Aneurysmal SAH

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07816159) titled 'MMA Infusion of Lidocaine for Treatment of Headache in Patients With Aneurysmal SAH' on Sept. 07.

Brief Summary: The purpose of the MIL-SAH trial is to evaluate the efficacy and safety of middle meningeal artery (MMA) lidocaine infusion for the treatment of headache in patients with aneurysmal subarachnoid hemorrhage (SAH). The trial aims to determine whether MMA lidocaine infusion reduces headache severity during the first 72 hours following endovascular aneurysm treatment compared with placebo.

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Headaches Associated With Subarachnoid Hemorrhage (SAH)

Intervent...